Publikationen, an denen er mitarbeitet Luis Manzano Espinosa (34)

2024

  1. Clinical suspicion, diagnosis and management of cardiac amyloidosis: update and executive summary

    Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 288-299

  2. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports

  3. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine

  4. Prognosis of acute heart failure in patients followed up in nursing homes in Spain: Results from the RICA registry

    Medicina Clinica, Vol. 162, Núm. 4, pp. 157-162

  5. Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial

    Revista Clinica Espanola, Vol. 224, Núm. 2, pp. 67-76

  6. The two different profiles in heart failure with preserved ejection fraction and type 2 diabetes mellitus: ischemic and diabetic

    Current Medical Research and Opinion, Vol. 40, Núm. 3, pp. 359-366

2023

  1. Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post-hoc analysis of the CLOROTIC trial

    European Journal of Heart Failure, Vol. 25, Núm. 10, pp. 1784-1793

  2. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

    European heart journal, Vol. 44, Núm. 5, pp. 411-421

  3. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  4. Current heart failure disease management and treatment in accredited units from cardiology and internal medicine in Spain

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 405-413

  5. Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure

    Revista Clinica Espanola, Vol. 223, Núm. 8, pp. 499-509

  6. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  7. Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  8. Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice

    Future cardiology, Vol. 19, Núm. 6, pp. 343-351

2022

  1. Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347

  2. Influence of the degree of anaemia on the prognosis of older adults with heart failure (SPAN-HF study)

    Medicina Clinica, Vol. 158, Núm. 4, pp. 167-172

2021

  1. Consensus on basic conduct during the hospital admission of patients with acute heart failure

    Revista Clinica Espanola, Vol. 221, Núm. 5, pp. 283-296

  2. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  3. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain

    PLoS ONE, Vol. 16, Núm. 8 August

2019

  1. De novo acute heart failure: Clinical features and one-year mortality in the Spanish nationwide Registry of Acute Heart Failure

    Medicina Clinica, Vol. 152, Núm. 4, pp. 127-134